Javascript is disabled

For further assistance, please click here.

Clinically proven to prevent and control asthma symptoms2,3

  • Makes using a spacer easy

    The only asthma inhaler with a built-in spacer3

     
  • Steps for using Aerospan

    play button
  • Announcing…

    MediKidz comic books for children with asthma!
    Written by doctors—created for kids. Ask your pediatrician.

    comic book

References: 1. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007. National Heart, Lung, and Blood Institute, National Institutes of Health. http://www.nhlbi.nih.gov/files/docs/guidelines/asthsumm.pdf. Published Ocober 2009. Accessed March 20, 2015. NIH publicaton 08-5846. 2. Corren J, Nelson H, Greos LS, et al. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Ann Allergy Asthma Immnol. 2001;87(5):405-411. 3. Aerospan [package insert]. Marlborough, MA: Acton Pharmaceuticals, Inc; 2013.

References: 1. National Heart, Lung, and Blood Institute, National Institutes of Health. What is asthma? http://www.nhlbi.nih.gov/health/health-topics/topics/asthma. Published August 4, 2014. Accessed March 20, 2015. 2. US National Library of Medicine, National Institutes of Health. MedlinePlus®. Asthma - children. http://www.nlm.nih.gov/medlineplus/ency/article/000990.htm. Updated May 14, 2014. Accessed March 20, 2015. 3. American Academy of Allergy Asthma & Immunology. Asthma. http://www.aaaai.org/conditions-and-treatments/asthma.aspx. Accessed March 20, 2015. 4. Glaxo Smith Kline. Asthma control test™. http://www.asthma.com/additional-resources/asthma-control-test.html. Accessed March 20, 2015. 5. American Lung Association. Measuring your peak flow rate. http://www.lung.org/lung-disease/asthma/taking-control-of-asthma/measuring-your-peak-flow-rate.html. Accessed March 20, 2015. 6. National Heart, Lung, and Blood Institute, National Institutes of Health. How is asthma diagnosed? http://www.nhlbi.nih.gov/health/health-topics/topics/asthma/diagnosis. Updated August 4, 2014. Accessed March 20, 2015. 7. Dweik RA, Boggs PB, Erzurum SC, et al; American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-615. 8. Data on file. Meda Pharmaceuticals Inc. 9. American Family Physician. Acute bronchitis: what you need to know. 1998;57(6):1281-1282. http://www.aafp.org/afp/1998/0315/p1281.html. Accessed March 20, 2015. 10. Asthma and Allergy Foundation of America. Asthma in infants. http://www.aafa.org/display.cfm?id=8&sub=17&cont=160. Updated 2005. Accessed March 20, 2015. 11. Mayo Clinic. Reactive airway disease: is it asthma?. http://www.mayoclinic.org/diseases-conditions/asthma/expert-answers/reactive-airway-disease/faq-20058010. Published February 5, 2013. Accessed March 20, 2015.

References: 1. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma—Summary Report 2007. National Heart, Lung, and Blood Institute, National Institutes of Health. http://www.nhlbi.nih.gov/files/docs/guidelines/asthsumm.pdf. Published October 2009. Accessed March 20, 2015. NIH publication 08-5846. 2. Aerospan [patient information]. Marlborough, MA: Acton Pharmaceuticals, Inc; 2012. 3. Asthma and Allergy Foundation of America. Asthma medications. http://www.aafa.org/display.cfm?id=8&sub=16&cont=42. Updated 2005. Accessed March 20, 2015. 4. Mayo Clinic. Asthma medications: know your options. http://www.mayoclinic.org/diseases-conditions/asthma/in-depth/asthma-medications/ART-20045557. Published Sept 20, 2012. Accessed March 20, 2015. 5. National Institutes of Health. PubMed Health. Fact sheet: medication for people with chronic asthma. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0072703/. Updated February 26, 2014. Accessed March 20, 2015. 6. National Heart, Lung, and Blood Institute, National Institutes of Health. What is asthma? http://www.nhlbi.nih.gov/health/health-topics/topics/asthma/. Updated August 4, 2014. Accessed March 20, 2015. 7. US National Library of Medicine, National Institutes of Health. MedlinePlus®. Asthma - children. http://www.nlm.nih.gov/medlineplus/ency/article/000990.htm. Updated May 14, 2014. Accessed March 20, 2015. 8. Medscape. Inhaled corticosteroids: is there an ideal therapy? http://www.medscape.org/viewarticle/467714. Accessed August 11, 2015.

References: 1. Aerospan [patient information]. Marlborough, MA: Acton Pharmaceuticals, Inc; 2012. 2. Aerospan [package insert]. Marlborough, MA: Acton Pharmaceuticals, Inc; 2013. 3. American Lung Association. Valved holding chambers and spacers. http://www.lung.org/lung-disease/asthma/taking-control-of-asthma/valved-holding-chambers-and-spacers.html. Updated 2005. Accessed March 20, 2015. 4. Asthma and Allergy Foundation of America. Metered-dose inhalers. http://www.aafa.org/display.cfm?id=8&sub=16&cont=57. Updated 2005. Accessed March 20, 2015. 5. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007. National Heart, Lung, and Blood Institute, National Institutes of Health. http://www.nhlbi.nih.gov/files/docs/guidelines/asthsumm.pdf. Published Ocober 2009. Accessed March 20, 2015. NIH publicaton 08-5846.

References: 1. Aerospan [patient information]. Marlborough, MA: Acton Pharmaceuticals, Inc; 2012. 2. FundingUniverse. Forest Laboratories, Inc. History. http://www.fundinguniverse.com/company-histories/forest-laboratories-inc-history/. Accessed March 20, 2015. 3. Acton Pharmaceuticals announces US Food and Drug Administration approval for AEROSPAN® (flunisolide HFA, 80 mcg) Inhalation Aerosol for asthma. Business Wire. September 20, 2012. http://www.businesswire.com/news/home/20120920005311/en/Acton-Pharmaceuticals-Announces-U.S.-Food-Drug-Administration#.Vcq4EUUc9UU. Accessed March 20, 2015.

 

Approved Uses for AEROSPAN Inhalation Aerosol

Prescription AEROSPAN is used for the long-term (maintenance) treatment of asthma to control and prevent asthma symptoms in adults and children 6 years of age and older.

AEROSPAN is not a bronchodilator and does not treat sudden symptoms of an asthma attack, such as wheezing, cough, shortness of breath, and chest pain or tightness. Always use a fast-acting bronchodilator medicine (rescue inhaler), such as albuterol, to treat sudden symptoms.

 

Important Safety Information

  • Do not use AEROSPAN
    • to treat the symptoms of a sudden asthma attack or status asthmaticus.
    • if you are allergic to flunisolide or any of the ingredients in AEROSPAN.
  • Use AEROSPAN exactly as your healthcare provider tells you to use it. Do not take more of your medicine, or take it more often than your healthcare provider tells you.
  • You must use AEROSPAN regularly. Do not stop using AEROSPAN, and do not change the amount of AEROSPAN you take, without talking to your doctor.
  • AEROSPAN may cause serious side effects, including:
    • fungal infections (thrush) in your mouth or throat. Tell your healthcare provider if you have any redness or white colored patches in your mouth or throat. Rinse your mouth with water after you use AEROSPAN.
    • immune system problems that may increase your risk of infections. You are more likely to get infections if you take medicines that may weaken your immune system. Avoid contact with people who have contagious diseases such as chicken pox or measles while you use AEROSPAN. Symptoms of an infection may include: fever, pain, aches, chills, feeling tired, nausea, and vomiting.
    • Tell your healthcare provider about any signs of infection while you are using AEROSPAN.
    • decreased adrenal function (adrenal insufficiency). Adrenal insufficiency is a condition in which the adrenal glands do not make enough steroid hormones. Symptoms of adrenal insufficiency include: tiredness, weakness, dizziness, nausea, and vomiting.
    • decreased bone mass (bone mineral density). People who use inhaled steroid medicines for a long time may have an increased risk of decreased bone mass which can affect bone strength. Talk to your healthcare provider about any concerns you may have about bone health.
    • slowed or delayed growth in children. A child’s growth should be checked regularly while taking AEROSPAN.
    • eye problems such as glaucoma and cataracts. If you have a history of glaucoma or cataracts or have a family history of eye problems, you should have regular eye exams while you use AEROSPAN.
    • increased wheezing (bronchospasm) can happen right away after using AEROSPAN. Stop using AEROSPAN and use an inhaled fast-acting bronchodilator (rescue inhaler) right away.
  • Tell your health care provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.
  • The most common side effects with AEROSPAN include: sore throat (pharyngitis), runny nose (rhinitis), headache, nausea, sinusitis, and increased cough.
  • Tell your healthcare provider about any side effect that bothers you or that does not go away.
  • These are not all of the possible side effects of AEROSPAN. For more information, ask your healthcare provider or pharmacist.

For additional information, please see the >Full Prescribing Information for Aerospan.

Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.